Orbis Allan Gray LTD Merck & Co., Inc. Transaction History

Orbis Allan Gray LTD

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2019 Aug 14, 2019	SELL	$69.84 - $81.59 $19.5 Million - $22.8 Million	-279,535 Closed	0 $0
Q1 2019 May 15, 2019	SELL	$69.58 - $79.36 $28.6 Million - $32.6 Million	-411,225 Reduced 59.53%	279,535 $23.2 Million
Q4 2018 Feb 14, 2019	SELL	$65.24 - $75.71 $6.49 Million - $7.53 Million	-99,469 Reduced 12.59%	690,760 $52.8 Million
Q3 2018 Nov 14, 2018	BUY	$57.69 - $67.84 $2.31 Million - $2.72 Million	40,128 Added 5.35%	790,229 $56.1 Million
Q2 2018 Aug 14, 2018	BUY	$50.83 - $59.72 $50,677 - $59,540	997 Added 0.13%	750,101 $45.5 Million
Q1 2018 May 15, 2018	BUY	$50.96 - $59.23 $3.53 Million - $4.11 Million	69,357 Added 10.2%	749,104 $40.8 Million
Q4 2017 Feb 14, 2018	BUY	$51.62 - $61.64 $6.15 Million - $7.34 Million	119,053 Added 21.23%	679,747 $38.2 Million
Q3 2017 Nov 14, 2017	BUY	$58.67 - $63.13 $32.9 Million - $35.4 Million	560,694	560,694 $35.9 Million

3,946

1.93B

15.9M

14.9M

Ticker MRK
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,533,280,000
Market Cap $210B
Description
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...

Get notified when there are updates to the investment portfolio of Orbis Allan Gray LTD, based on Form 13F filings with the SEC.

Stay updated on Orbis Allan Gray LTD with notifications on news.